How do I perform hematopoietic progenitor cell selection?
نویسندگان
چکیده
منابع مشابه
How do I approach ABOincompatible hematopoietic progenitor cell transplantation? CME
H uman leukocyte antigen (HLA) matching is critically important for successful hematopoietic progenitor cell (HPC) transplantation because the rates of engraftment and transplant outcomes are strongly influenced by the degree of match. This is largely because HLA antigens are expressed on immature pluripotent stem cells. In contrast, ABO incompatibility is not a barrier to successful HPC transp...
متن کاملWhere Do Se-trees Perform? (part I)
As a classiier, a Set Enumeration (SE) tree can be viewed as a generalization of decision trees. We empirically characterize domains in which SE-trees are particularly advantageous relative to decision trees. Speciically, we show that: 1. SE-trees excel in domains in which relatively few examples are available; and 2. SE-trees excel in noisy domains. In noisy domains, we discover that SE-trees ...
متن کاملHow Well Do Selection Models Perform? Assessing the Acuracy of Art Auction Pre-sale Estimates.
Art auction catalogs provide a pre-sale prediction interval for the price each item is expected to fetch. When the owner consigns art work to the auction house, a reserve price is agreed upon, which is not announced to the bidders. If the highest bid does not reach it, the item is brought in. Since only the prices of the sold items are published, analysts only have a biased sample to examine du...
متن کاملHow I Treat How I assess comorbidities before hematopoietic cell transplantation
Organ dysfunctions (comorbidities) were found to be associated with the outcome of treatment of a given primary disease and, in particular, cancer. In 2005, a hematopoietic cell transplantationcomorbidity index (HCT-CI) was introduced as a measure of organ dysfunctions that was suited for recipients of HCT. The HCT-CI was developed from the historical Charlson comorbidity index after introducin...
متن کاملHow I treat How I treat cytomegalovirus in hematopoietic cell transplant recipients
Cytomegalovirus (CMV) continues to cause major complications after hematopoietic cell transplantation (HCT). Over the past decade, most centers have adopted preemptive antiviral treatment or prophylaxis strategies to prevent CMV disease. Both strategies are effective but also have shortcomings with presently available drugs. Here, we review aspects of CMV treatment and prevention in HCT recipie...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Transfusion
سال: 2016
ISSN: 0041-1132
DOI: 10.1111/trf.13534